Protara Therapeutics Inc. (TARA)
NASDAQ: TARA
· Real-Time Price · USD
5.72
0.36 (6.72%)
At close: Oct 15, 2025, 3:59 PM
5.80
1.40%
After-hours: Oct 15, 2025, 07:03 PM EDT
6.72% (1D)
| Bid | 5.26 |
| Market Cap | 220.69M |
| Revenue (ttm) | 332K |
| Net Income (ttm) | -50.86M |
| EPS (ttm) | -1.56 |
| PE Ratio (ttm) | -3.67 |
| Forward PE | -3.2 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.9 |
| Volume | 499,989 |
| Avg. Volume (20D) | 390,643 |
| Open | 5.34 |
| Previous Close | 5.36 |
| Day's Range | 5.30 - 5.73 |
| 52-Week Range | 1.77 - 10.48 |
| Beta | 1.53 |
| Ex-Dividend Date | n/a |
About TARA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TARA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TARA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
-18.52%
Protara Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
5 months ago
+6.6%
Protara Therapeutics shares are trading higher after the company announced it will review the interim data from its Phase 2 ADVANCED-2 trial.
